{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:15:27Z","timestamp":1789593327173,"version":"build-2803163510"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Lymphoblastic leukemia\/lymphoma, a neoplasm of precursor B or T lineage lymphoid cells, usually involves the bone marrow and peripheral blood, and may involve nodal and\/or extranodal sites. The diagnosis is based on morphologic assessment, immunophenotypic analysis, usually by flow cytometry, and genetic analysis, including cytogenetics and FISH analysis, as well as molecular diagnostic analysis. This review will focus on the flow cytometric immunophenotypic findings in B- and T-lymphoblastic leukemia\/lymphoma, which include expressions of early B or T cell markers, low-level expressions of CD45, as well as expressions of terminal deoxynucleotidyl transferase (TdT), and, in many cases, stem\/progenitor cell marker CD34.<\/jats:p>","DOI":"10.3390\/cancers17071111","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:58:43Z","timestamp":1742972323000},"page":"1111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Flow Cytometric Evaluation of B- and T-Lymphoblastic Leukemia\/Lymphoma"],"prefix":"10.3390","volume":"17","author":[{"given":"David M.","family":"Dorfman","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"ref_1","unstructured":"(2024, November 26). WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours, Available online: https:\/\/publications.iarc.who.int\/637."},{"key":"ref_2","unstructured":"Wood, B.L., and Gujral, S. (2024). B-lymphoblastic leukemia\/lymphoma, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_3","unstructured":"WHO Classification of Tumours Editorial Board (2024). T-lymphoblastic leukemia\/lymphoma, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_4","unstructured":"Dorfman, D.M., Karlon, W.J., and Linden, M.A. (2023). Overview: Flow cytometry of B-lymphoblastic leukemia and immature B-cells. Color Atlas of Flow Cytometry: An Illustrated Field Guide Based on Proficiency Testing, College of American Pathologists Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1309\/AJCPFBCFXP94AKWJ","article-title":"B-Cell Transcription Factor Expression and Immunoglobulin Gene Rearrangement Frequency in Acute Myeloid Leukemia with t(8;21)(q22;q22)","volume":"140","author":"Johnson","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5858\/2000-124-0704-IDOCIP","article-title":"Immunoperoxidase Detection of CD10 in PrecursorT-Lymphoblastic Lymphoma\/Leukemia","volume":"124","author":"Aguilera","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1309\/AJCP8G5RMTWUEMUU","article-title":"Characterization of Immunophenotypic Aberrancies in 200 Cases of B Acute Lymphoblastic Leukemia","volume":"132","author":"Seegmiller","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_8","unstructured":"Wood, B.L. (2024). Acute leukemias of mixed or ambiguous lineage: Introduction, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002770050424","article-title":"Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia","volume":"77","author":"Ratei","year":"1998","journal-title":"Ann. Hematol."},{"key":"ref_10","unstructured":"Dorfman, D.M., Karlon, W.J., and Linden, M.A. (2023). CD45-negative or misgated B-lymphoblastic leukemia. Color Atlas of Flow Cytometry: An Illustrated Field Guide Based on Proficiency Testing, College of American Pathologists Press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cyto.b.22153","article-title":"Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia","volume":"106","author":"Boris","year":"2024","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/cyto.b.21866","article-title":"CD304\/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia","volume":"98","author":"Gudapati","year":"2020","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.b.21486","article-title":"Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD","volume":"94","author":"Tembhare","year":"2018","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_15","first-page":"112429","article-title":"Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia","volume":"475","author":"Theunissen","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1309\/AJCPO4DS0GTLSOEI","article-title":"Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors (\u201chematogones\u201d) and B lymphoblastic leukemia blasts","volume":"132","author":"Hassanein","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cyto.b.21745","article-title":"CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping","volume":"96","author":"Bras","year":"2019","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1002\/cpcy.44","article-title":"Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies","volume":"86","author":"Cherian","year":"2018","journal-title":"Curr. Protoc. Cytom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cyto.b.21833","article-title":"Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia\/Lymphoma","volume":"96","author":"DiGiuseppe","year":"2019","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/2QE3A6EKQ8UYDYRC","article-title":"Precursor T-Cell Acute Lymphoblastic Leukemia\/Lymphoblastic Lymphoma and Acute Biphenotypic Leukemias","volume":"127","author":"Han","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_22","unstructured":"Dorfman, D.M., Karlon, W.J., and Linden, M.A. (2023). Overview: Flow cytometry of T-lymphoblastic leukemia and immature T-cells. Color Atlas of Flow Cytometry: An Illustrated Field Guide Based on Proficiency Testing, College of American Pathologists Press."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: A Children\u2019s Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41379-021-00739-4","article-title":"Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: A study from the Bone Marrow Pathology Group","volume":"34","author":"Weinberg","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: A subtype of very high-risk acute lym-phoblastic leukaemia","volume":"10","author":"Mullighan","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_26","unstructured":"WHO Classification of Tumours Editorial Board (2024). Early T-precursor lymphoblastic leukemia\/lymphoma, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_27","unstructured":"Dorfman, D.M., Karlon, W.J., and Linden, M.A. (2023). Early T precursor (ETP) lymphoblastic leukemia. Color Atlas of Flow Cytometry: An Illustrated Field Guide Based on Proficiency Testing, College of American Pathologists Press."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10428190310001598008","article-title":"Flow Cytometry in the Diagnosis of Mediastinal Tumors with Emphasis on Differentiating Thymocytes from Precursor T-Lymphoblastic Lymphoma\/Leukemia","volume":"45","author":"Gorczyca","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1309\/K2FY1TED8GEGFLNG","article-title":"Flow cytometry in the differential diagnosis of lymphocyte\u2013rich thymoma from precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"121","author":"Li","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ajcp\/aqy173","article-title":"Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas","volume":"151","author":"Novikov","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ajcp\/aqab098","article-title":"Flow cytometric evaluation of surface and cytoplasmic TRBC1 expression in the differen-tial diagnosis of immature T-cell proliferations","volume":"157","author":"Horna","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-024-01002-0","article-title":"Dual T-cell constant \u03b2 chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry","volume":"14","author":"Horna","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cll.2017.07.002","article-title":"Flow cytometry of T-cells and T-cell neoplasms","volume":"37","author":"Craig","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MPH.0000000000002967","article-title":"Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging Diagnosis","volume":"47","author":"Cheng","year":"2024","journal-title":"J. Pediatr. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.leu.2403303","article-title":"CD99 expression in T-lineage ALL: Implications for flow cytometric detection of minimal residual disease","volume":"18","author":"Dworzak","year":"2004","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V118.21.2547.2547","article-title":"High-throughput screening by flow cytometry identifies reduced expression of CD48 as a universal characteristic of T-ALL and a suitable target for minimal residual disease (MRD) detection","volume":"118","author":"Wood","year":"2011","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cyto.a.24805","article-title":"FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report","volume":"105","author":"Kowarsch","year":"2024","journal-title":"Cytom. A"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ajcp\/106.2.185","article-title":"Lymphoid-Associated Antigen Expression by Acute Myeloid Leukemia","volume":"106","author":"Launder","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_39","unstructured":"Chen, W. (2024). Acute undifferentiated leukemia, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: Clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s11912-022-01252-w","article-title":"Mixed phenotype\/lineage leukemia: Has anything changed for 2021 on diagnosis, classification, and treatment?","volume":"24","author":"Porwit","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_42","unstructured":"Chen, W. (2024). Acute leukemia of ambiguous lineage NOS, WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet]."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cll.2023.05.004","article-title":"Advances in Clinical Mass Cytometry","volume":"43","author":"Koladiya","year":"2023","journal-title":"Clin. Lab. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2023-181565","article-title":"One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia","volume":"142","author":"Wu","year":"2023","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Callebaut","year":"2015","journal-title":"Cytom. Part A"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.b.21252","article-title":"Detection of minimal residual disease in B lymphoblastic leukemia using viSNE","volume":"88","author":"DiGiuseppe","year":"2015","journal-title":"Cytom. Part B Clin. Cytom."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:00:31Z","timestamp":1760029231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17071111"],"URL":"https:\/\/doi.org\/10.3390\/cancers17071111","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}